The etiopathogenesis and the classification of oncocytic (Hurthle cell) tumors of the thyroid is reviewed with an emphasis on the role played by mitochondrial and nuclear genetic abnormalities that interfere with mitochondrial function. Oxyphilia is classified into primary or secondary and the so-called Hurthle cell carcinoma is divided into oncocytic (Hurthle cell) variants of papillary and follicular carcinoma.
1. LiVolsi V. Surgical pathology of the thyroid. WB Saunders, Philadelphia, 1990
2.
2. Rosai J. Tumors of the thyroid gland, 3rd series. Armed Forces Institute of Pathology, Washington, DC, 1993
3.
3. Maiximo V, Sobrinho-Simoes M. Hurthle cell tumors of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch437:107-115, 2000
4.
4. Nesland JM, Sobrinho-Simoes MA, Holm R, Sambade MC, Johannessen JV. Huirthle cell lesions of the thyroid: A combined study using transmission electron microscopy, scanning electron microscopy and immunocytochemistry. Ultrastruct Pathol8:269-290, 1985
5.
5. Sobrinho-Sim6es MA, Nesland JM, Holm R, Sambade C, Johannessen JV. Huirthle cell-and mitochondrion-rich papillary carcinomas of the thyroid gland. An ultrastructural and immunocytochemical study. Ultrastruct Pathol8:131-142, 1985
6.
6. Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology. A study with emphasis on Hiirthle cell tumors. Am J Pathol160:1857-1865, 2002
7.
7. Muller-Hocker J, Jacob U, Seibel P. Hashimoto thyroiditis is associated with defects of cytochrome-c oxidase in oxyphil Askanazy cells and with the common deletion (4,977) of mitochondrial DNA. Ultrastruct Pathol22:91-100, 1998
8.
8. Maximo V, Sobrinho-Sim6es M. Mitochondrial DNA ‘common’ deletion in Hurthle cell lesions of the thyroid. (Letter to the editor.) J Pathol192:561-562, 2000
9.
9. Lewis PD, Baxter P, Griffiths AP, Parry JM, Skibinski DOF. Detection of damage to the mitochondrial genome in the oncocytic cells of Warthins tumor. J Pathol191:274-281, 2000
10.
10. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer3:193-202, 2003
11.
11. Allia E, Cassoni P, Marrocco T, Volante M, Bussolati B, Wong M, Clark OH, Papotti M. Oxyphilic and nonoxyphilic thyroid carcinoma cell lines differ in expressing apoptosis-related genesJ Endocrinol Invest26:660-667, 2003
12.
12. DeLellis R. Tumors of the thyroid and parathyroid. In Tumors of endocrine organs. Lyon, France, World Health Organization Classification of Tumors, 2004; (in press)
14. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, SobrinhoSim6es M. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene22:4578-4580, 2003
15.
15. Trovisco V, VieiraCastro I, Soares P, Maximo V, Silva P, Magalhaes J, Abrosimov A, Guiu XM, SobrinhoSimoes M. BRAF mutations are associated with some histiotypes of papillary thyroid carcinoma. J Pathol202:2147-2251, 2004
16.
16. Rosai J, LiVolsi VA, Sobrinho-Sim6es M, Williams ED. Renaming papillary microcarcinoma of the thyroid gland: The Porto proposal. Int J Surg Pathol11:249-251, 2003
17.
17. Williams ED. Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol8:181-183, 2000
18.
18. Evans HL, Vassilopoulou-Sellin R. Follicular and Hiurthle cell carcinomas of the thyroid: A comparative study. Am J Surg Pathol22:151-152, 1998
19.
19. Maximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Sim6es M. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death is linked to mitochondrion-rich (Hurthle cell) tumors of the thyroid, 2004 (submitted)
